 Stephanie Crowley
Concepts (234)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Circadian Rhythm | 37 | 2026 | 514 | 7.250 |
Why?
| | Sleep | 37 | 2026 | 901 | 5.660 |
Why?
| | Melatonin | 22 | 2026 | 163 | 4.030 |
Why?
| | Light | 15 | 2026 | 411 | 2.990 |
Why?
| | Circadian Clocks | 5 | 2026 | 59 | 2.060 |
Why?
| | Sleep Disorders, Circadian Rhythm | 12 | 2021 | 52 | 2.050 |
Why?
| | Work Schedule Tolerance | 4 | 2018 | 51 | 1.360 |
Why?
| | Biological Clocks | 4 | 2018 | 49 | 1.310 |
Why?
| | Adolescent Behavior | 3 | 2025 | 501 | 1.170 |
Why?
| | Wakefulness | 5 | 2017 | 169 | 1.130 |
Why?
| | Affect | 2 | 2025 | 318 | 1.070 |
Why?
| | Sleep Deprivation | 2 | 2026 | 206 | 0.990 |
Why?
| | Schools | 5 | 2022 | 453 | 0.980 |
Why?
| | Adolescent Development | 2 | 2018 | 72 | 0.860 |
Why?
| | Seasons | 6 | 2021 | 556 | 0.850 |
Why?
| | Saliva | 9 | 2015 | 249 | 0.730 |
Why?
| | Puberty | 2 | 2015 | 140 | 0.730 |
Why?
| | Stress, Physiological | 1 | 2025 | 453 | 0.710 |
Why?
| | Repressor Proteins | 1 | 2025 | 437 | 0.710 |
Why?
| | Hematopoietic Stem Cells | 1 | 2025 | 420 | 0.710 |
Why?
| | Interleukin-2 | 2 | 2020 | 437 | 0.690 |
Why?
| | Time Factors | 16 | 2026 | 7183 | 0.660 |
Why?
| | Adolescent | 25 | 2026 | 22453 | 0.650 |
Why?
| | Actigraphy | 6 | 2025 | 145 | 0.640 |
Why?
| | Single-Domain Antibodies | 1 | 2020 | 15 | 0.620 |
Why?
| | Photoperiod | 4 | 2017 | 55 | 0.610 |
Why?
| | Blood Glucose | 5 | 2017 | 2330 | 0.580 |
Why?
| | Homeostasis | 4 | 2018 | 640 | 0.560 |
Why?
| | Histocompatibility Antigens Class II | 1 | 2020 | 364 | 0.550 |
Why?
| | Diabetes Mellitus, Type 2 | 7 | 2020 | 2584 | 0.540 |
Why?
| | Sleep Wake Disorders | 5 | 2024 | 302 | 0.530 |
Why?
| | Sex Characteristics | 3 | 2017 | 791 | 0.490 |
Why?
| | Female | 43 | 2026 | 78376 | 0.480 |
Why?
| | Male | 39 | 2026 | 72406 | 0.460 |
Why?
| | Jet Lag Syndrome | 5 | 2022 | 13 | 0.450 |
Why?
| | Humans | 58 | 2026 | 144957 | 0.430 |
Why?
| | Specimen Handling | 1 | 2015 | 186 | 0.410 |
Why?
| | Peptides | 1 | 2020 | 998 | 0.410 |
Why?
| | Melanoma | 2 | 2020 | 761 | 0.410 |
Why?
| | Models, Neurological | 1 | 2015 | 254 | 0.400 |
Why?
| | Sleep Stages | 1 | 2012 | 75 | 0.370 |
Why?
| | Students | 3 | 2019 | 663 | 0.360 |
Why?
| | Feeding and Eating Disorders | 1 | 2014 | 163 | 0.350 |
Why?
| | Adult | 27 | 2025 | 40506 | 0.350 |
Why?
| | Occupational Health | 1 | 2014 | 209 | 0.340 |
Why?
| | Feeding Behavior | 2 | 2014 | 685 | 0.340 |
Why?
| | Depression | 4 | 2017 | 1559 | 0.310 |
Why?
| | Surveys and Questionnaires | 12 | 2024 | 6053 | 0.280 |
Why?
| | Aging | 2 | 2015 | 1966 | 0.270 |
Why?
| | Child Development | 1 | 2011 | 484 | 0.240 |
Why?
| | Memory Consolidation | 1 | 2026 | 14 | 0.240 |
Why?
| | Cell Self Renewal | 1 | 2025 | 53 | 0.220 |
Why?
| | Body Weight | 2 | 2019 | 978 | 0.220 |
Why?
| | Inhibitor of Apoptosis Proteins | 2 | 2023 | 47 | 0.220 |
Why?
| | Darkness | 2 | 2005 | 26 | 0.220 |
Why?
| | Hematopoiesis | 1 | 2025 | 194 | 0.210 |
Why?
| | Phototherapy | 3 | 2013 | 48 | 0.200 |
Why?
| | Clothing | 1 | 2003 | 23 | 0.200 |
Why?
| | Arousal | 1 | 2004 | 157 | 0.200 |
Why?
| | Climate Change | 1 | 2026 | 199 | 0.200 |
Why?
| | Gadolinium | 1 | 2024 | 84 | 0.200 |
Why?
| | Sleep Initiation and Maintenance Disorders | 2 | 2024 | 194 | 0.200 |
Why?
| | Young Adult | 8 | 2021 | 14126 | 0.200 |
Why?
| | Mood Disorders | 1 | 2004 | 140 | 0.200 |
Why?
| | Time Management | 1 | 2023 | 21 | 0.190 |
Why?
| | Middle Aged | 13 | 2025 | 35928 | 0.180 |
Why?
| | DNA Breaks, Double-Stranded | 1 | 2022 | 56 | 0.180 |
Why?
| | NF-kappa B | 2 | 2023 | 662 | 0.180 |
Why?
| | Pediatric Obesity | 2 | 2019 | 638 | 0.180 |
Why?
| | Neoplasms | 3 | 2024 | 2884 | 0.170 |
Why?
| | Child | 10 | 2024 | 22657 | 0.170 |
Why?
| | Mice | 7 | 2025 | 18365 | 0.170 |
Why?
| | Li-Fraumeni Syndrome | 1 | 2020 | 15 | 0.170 |
Why?
| | Phagocytes | 1 | 2021 | 81 | 0.160 |
Why?
| | Dermatitis, Atopic | 1 | 2024 | 321 | 0.160 |
Why?
| | Cellular Reprogramming | 1 | 2021 | 103 | 0.160 |
Why?
| | Adie Syndrome | 1 | 2020 | 2 | 0.160 |
Why?
| | Camelids, New World | 1 | 2020 | 9 | 0.160 |
Why?
| | Histocompatibility Antigens Class I | 1 | 2021 | 202 | 0.150 |
Why?
| | Vaccines, Subunit | 1 | 2020 | 53 | 0.150 |
Why?
| | Photic Stimulation | 2 | 2015 | 264 | 0.150 |
Why?
| | United States | 6 | 2025 | 15988 | 0.150 |
Why?
| | Peyer's Patches | 1 | 2019 | 7 | 0.150 |
Why?
| | Hematopoietic Stem Cell Transplantation | 1 | 2025 | 676 | 0.150 |
Why?
| | Immunoglobulin Class Switching | 1 | 2019 | 21 | 0.150 |
Why?
| | Universities | 1 | 2022 | 452 | 0.150 |
Why?
| | Drug Synergism | 1 | 2020 | 357 | 0.150 |
Why?
| | Molecular Mimicry | 1 | 2019 | 37 | 0.140 |
Why?
| | Receptors, Interleukin-2 | 1 | 2019 | 64 | 0.140 |
Why?
| | Immunotherapy | 2 | 2021 | 657 | 0.140 |
Why?
| | Retinal Ganglion Cells | 1 | 2020 | 121 | 0.140 |
Why?
| | Natural Killer T-Cells | 1 | 2019 | 67 | 0.140 |
Why?
| | Homeodomain Proteins | 1 | 2022 | 524 | 0.140 |
Why?
| | Jamaica | 3 | 2025 | 8 | 0.140 |
Why?
| | Cancer Vaccines | 1 | 2020 | 160 | 0.140 |
Why?
| | Body Height | 1 | 2019 | 202 | 0.140 |
Why?
| | Interleukin-15 | 1 | 2019 | 97 | 0.140 |
Why?
| | Immunoglobulin Fragments | 1 | 2018 | 11 | 0.140 |
Why?
| | Ghana | 3 | 2025 | 43 | 0.140 |
Why?
| | Antigens, Neoplasm | 1 | 2020 | 272 | 0.140 |
Why?
| | Mice, Knockout | 1 | 2025 | 3125 | 0.140 |
Why?
| | Cell Line, Tumor | 3 | 2023 | 3550 | 0.130 |
Why?
| | Immunoglobulin Fc Fragments | 1 | 2018 | 41 | 0.130 |
Why?
| | Drug Design | 1 | 2019 | 173 | 0.130 |
Why?
| | Immunoglobulin G | 2 | 2019 | 893 | 0.130 |
Why?
| | Nanoparticles | 1 | 2024 | 520 | 0.130 |
Why?
| | CTLA-4 Antigen | 1 | 2018 | 104 | 0.130 |
Why?
| | Shift Work Schedule | 1 | 2017 | 10 | 0.130 |
Why?
| | Weight Gain | 1 | 2021 | 559 | 0.130 |
Why?
| | Diabetic Retinopathy | 1 | 2020 | 208 | 0.130 |
Why?
| | Adaptation, Physiological | 2 | 2016 | 570 | 0.130 |
Why?
| | South Africa | 3 | 2025 | 261 | 0.130 |
Why?
| | Human Migration | 1 | 2017 | 26 | 0.130 |
Why?
| | Autoantigens | 1 | 2020 | 429 | 0.130 |
Why?
| | Africa | 1 | 2017 | 116 | 0.120 |
Why?
| | Tumor Suppressor Protein p53 | 1 | 2020 | 531 | 0.120 |
Why?
| | Xenograft Model Antitumor Assays | 1 | 2020 | 930 | 0.120 |
Why?
| | Recombinant Proteins | 1 | 2020 | 1371 | 0.120 |
Why?
| | T-Lymphocytes | 2 | 2023 | 1982 | 0.120 |
Why?
| | Metabolic Syndrome | 1 | 2020 | 354 | 0.120 |
Why?
| | Animals | 7 | 2025 | 38109 | 0.120 |
Why?
| | Psychomotor Performance | 2 | 2012 | 328 | 0.120 |
Why?
| | Sleep-Wake Transition Disorders | 1 | 2015 | 4 | 0.120 |
Why?
| | Preoptic Area | 1 | 2015 | 8 | 0.120 |
Why?
| | Suprachiasmatic Nucleus | 1 | 2015 | 19 | 0.120 |
Why?
| | Thailand | 1 | 2015 | 18 | 0.120 |
Why?
| | Europe | 1 | 2017 | 412 | 0.120 |
Why?
| | Body Mass Index | 5 | 2021 | 2438 | 0.120 |
Why?
| | Glycemic Index | 1 | 2015 | 26 | 0.120 |
Why?
| | Genetic Variation | 1 | 2020 | 984 | 0.110 |
Why?
| | Sexual Maturation | 1 | 2015 | 51 | 0.110 |
Why?
| | Bacteria | 1 | 2021 | 889 | 0.110 |
Why?
| | Pancreatic Neoplasms | 1 | 2023 | 927 | 0.110 |
Why?
| | Occupations | 1 | 2014 | 51 | 0.110 |
Why?
| | Neural Inhibition | 1 | 2015 | 178 | 0.110 |
Why?
| | Child, Preschool | 4 | 2024 | 11799 | 0.110 |
Why?
| | Aged | 6 | 2020 | 25947 | 0.100 |
Why?
| | Breakfast | 1 | 2013 | 20 | 0.100 |
Why?
| | CD8-Positive T-Lymphocytes | 1 | 2020 | 917 | 0.100 |
Why?
| | Gastrointestinal Microbiome | 1 | 2021 | 771 | 0.100 |
Why?
| | Seychelles | 2 | 2025 | 2 | 0.100 |
Why?
| | Central Nervous System Depressants | 1 | 2013 | 83 | 0.100 |
Why?
| | Syndrome | 1 | 2014 | 380 | 0.100 |
Why?
| | Vitamin B 12 | 1 | 2013 | 127 | 0.100 |
Why?
| | Glucose Intolerance | 1 | 2014 | 142 | 0.090 |
Why?
| | Nerve Net | 1 | 2015 | 285 | 0.090 |
Why?
| | Longitudinal Studies | 2 | 2024 | 2947 | 0.090 |
Why?
| | Gene Expression Profiling | 1 | 2019 | 1786 | 0.090 |
Why?
| | Psychotherapy | 1 | 2013 | 191 | 0.090 |
Why?
| | Eating | 1 | 2014 | 392 | 0.090 |
Why?
| | Depressive Disorder | 1 | 2014 | 387 | 0.080 |
Why?
| | Random Allocation | 1 | 2010 | 363 | 0.080 |
Why?
| | Cognition | 1 | 2017 | 1269 | 0.070 |
Why?
| | Age Factors | 2 | 2017 | 3335 | 0.070 |
Why?
| | Energy Intake | 3 | 2017 | 500 | 0.070 |
Why?
| | Self Report | 2 | 2024 | 873 | 0.070 |
Why?
| | Algorithms | 1 | 2015 | 1839 | 0.060 |
Why?
| | Prevalence | 1 | 2014 | 2836 | 0.060 |
Why?
| | Neurons | 1 | 2015 | 1642 | 0.060 |
Why?
| | Cross-Sectional Studies | 3 | 2024 | 5872 | 0.060 |
Why?
| | Aviation | 1 | 2005 | 10 | 0.060 |
Why?
| | Work | 1 | 2005 | 23 | 0.060 |
Why?
| | Disorders of Excessive Somnolence | 1 | 2004 | 38 | 0.050 |
Why?
| | Lighting | 1 | 2003 | 30 | 0.050 |
Why?
| | Body Temperature | 1 | 2004 | 229 | 0.050 |
Why?
| | Rest | 1 | 2024 | 124 | 0.050 |
Why?
| | Tissue Distribution | 1 | 2024 | 334 | 0.050 |
Why?
| | Memory Disorders | 1 | 2004 | 194 | 0.050 |
Why?
| | Signal Transduction | 3 | 2022 | 5233 | 0.050 |
Why?
| | Precursor Cells, B-Lymphoid | 1 | 2022 | 41 | 0.050 |
Why?
| | Mental Recall | 1 | 2004 | 222 | 0.050 |
Why?
| | Pregnancy Trimester, Third | 1 | 2003 | 115 | 0.050 |
Why?
| | Immunity | 1 | 2023 | 139 | 0.050 |
Why?
| | Social Class | 1 | 2024 | 268 | 0.040 |
Why?
| | Cells, Cultured | 2 | 2020 | 4155 | 0.040 |
Why?
| | Health Status | 1 | 2007 | 836 | 0.040 |
Why?
| | Depression, Postpartum | 1 | 2003 | 128 | 0.040 |
Why?
| | Germ Cells | 1 | 2020 | 66 | 0.040 |
Why?
| | Fear | 1 | 2024 | 366 | 0.040 |
Why?
| | Reflex, Pupillary | 1 | 2020 | 6 | 0.040 |
Why?
| | Cognition Disorders | 1 | 2004 | 538 | 0.040 |
Why?
| | DNA Damage | 1 | 2022 | 430 | 0.040 |
Why?
| | Time | 1 | 2019 | 86 | 0.040 |
Why?
| | Nuclear Transfer Techniques | 1 | 2019 | 5 | 0.040 |
Why?
| | Promyelocytic Leukemia Zinc Finger Protein | 1 | 2019 | 8 | 0.040 |
Why?
| | Nuclear Receptor Subfamily 1, Group F, Member 3 | 1 | 2019 | 14 | 0.040 |
Why?
| | Precision Medicine | 1 | 2024 | 458 | 0.040 |
Why?
| | Meals | 1 | 2021 | 130 | 0.040 |
Why?
| | Galactosylceramides | 1 | 2019 | 27 | 0.040 |
Why?
| | Neuropsychological Tests | 1 | 2004 | 1137 | 0.040 |
Why?
| | RNA, Ribosomal, 16S | 1 | 2021 | 559 | 0.040 |
Why?
| | Cohort Studies | 2 | 2021 | 5965 | 0.040 |
Why?
| | Interleukin-2 Receptor alpha Subunit | 1 | 2019 | 80 | 0.040 |
Why?
| | T-Box Domain Proteins | 1 | 2019 | 106 | 0.040 |
Why?
| | Interleukin-4 | 1 | 2019 | 206 | 0.030 |
Why?
| | Epidemics | 1 | 2019 | 98 | 0.030 |
Why?
| | Sequence Analysis, DNA | 1 | 2021 | 824 | 0.030 |
Why?
| | Protein Stability | 1 | 2019 | 178 | 0.030 |
Why?
| | Feces | 1 | 2021 | 513 | 0.030 |
Why?
| | Genetic Testing | 1 | 2020 | 482 | 0.030 |
Why?
| | Interferon-gamma | 1 | 2021 | 784 | 0.030 |
Why?
| | Diet | 2 | 2017 | 1275 | 0.030 |
Why?
| | Hydrocortisone | 1 | 2020 | 304 | 0.030 |
Why?
| | Disease Models, Animal | 2 | 2019 | 4569 | 0.030 |
Why?
| | Crystallography, X-Ray | 1 | 2019 | 493 | 0.030 |
Why?
| | B-Lymphocytes | 1 | 2022 | 877 | 0.030 |
Why?
| | Adipose Tissue | 1 | 2021 | 653 | 0.030 |
Why?
| | Colonic Neoplasms | 1 | 2019 | 260 | 0.030 |
Why?
| | Mothers | 1 | 2003 | 775 | 0.030 |
Why?
| | Severity of Illness Index | 1 | 2004 | 2925 | 0.030 |
Why?
| | Protein Domains | 1 | 2018 | 313 | 0.030 |
Why?
| | Binding Sites | 1 | 2019 | 1331 | 0.030 |
Why?
| | Amino Acid Sequence | 1 | 2019 | 2157 | 0.030 |
Why?
| | Public Health | 1 | 2019 | 566 | 0.030 |
Why?
| | Apoptosis | 1 | 2023 | 2430 | 0.030 |
Why?
| | Computer Simulation | 1 | 2019 | 1026 | 0.030 |
Why?
| | Models, Molecular | 1 | 2019 | 1619 | 0.020 |
Why?
| | Macrophages | 1 | 2021 | 1511 | 0.020 |
Why?
| | Inflammation | 1 | 2024 | 2880 | 0.020 |
Why?
| | Cell Differentiation | 1 | 2019 | 2050 | 0.020 |
Why?
| | Prospective Studies | 1 | 2024 | 7997 | 0.020 |
Why?
| | Linear Models | 1 | 2013 | 854 | 0.020 |
Why?
| | Antibodies, Monoclonal | 1 | 2018 | 1524 | 0.020 |
Why?
| | Vaccination | 1 | 2019 | 1423 | 0.020 |
Why?
| | Mice, Inbred C57BL | 1 | 2018 | 5997 | 0.020 |
Why?
| | Risk Factors | 1 | 2020 | 10792 | 0.010 |
Why?
| | MMPI | 1 | 2005 | 8 | 0.010 |
Why?
| | Placebos | 1 | 2005 | 193 | 0.010 |
Why?
| | Delayed-Action Preparations | 1 | 2005 | 183 | 0.010 |
Why?
| | Personality | 1 | 2005 | 132 | 0.010 |
Why?
| | Insulin | 1 | 2013 | 2507 | 0.010 |
Why?
| | Aged, 80 and over | 1 | 2013 | 8279 | 0.010 |
Why?
| | Pregnancy Complications | 1 | 2003 | 592 | 0.010 |
Why?
| | Pregnancy | 1 | 2003 | 7191 | 0.000 |
Why?
|
|
Crowley's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|